Liver Diseases: all 2,094 studies
Page 15 of 21. Open to participants first (390), then studies with results posted, then the rest; newest registration first within each.
- Pulmonary Rehabilitation in End-Stage Liver DiseaseTerminatedNCT03266575Not applicable
- Utility of Point Shear-wave Elastography to Assess for Hepatic & Pancreatic Fibrosis in Pediatric CF PatientsStatus unknownNCT03264950Not applicable
- Safety Tolerability, and PK of RYI-018 After Repeat Dosing in Subjects With Non-Alcoholic Fatty Liver Disease (NAFLD)CompletedNCT03261739Phase 1
- Comparison of MR Elastography Methods Without and With Compressed SensingCompletedNCT03260660
- Hepatic Urea Nitrogen Handling in Patients With NASHActive, not recruitingNCT03260036
- Copeptin and Nonalcoholic Fatty Liver DiseaseStatus unknownNCT03254563
- Serum Ferritin as a Non-invasive Marker in Prediction of Hepatic Fibrosis Among NAFLD PatientsCompletedNCT03250572
- Long Term Follow-up of Hepatitis C Cured PatientsCompletedNCT03246048
- Combining MRI Steatosis Assessment and Transient Elastography to Improve Liver Fibrosis Diagnosis in Non Alcoholic Fatty Liver DiseaseCompletedNCT03245606
- Remote Ischemic Conditioning in Abdominal SurgeryStatus unknownNCT03234543Not applicable
- The Comparison of Effect Between Salsalate and Placebo in Osteoarthritis With Nonalcoholic Fatty Liver DiseaseCompletedNCT03222206Phase 4
- Kuopio Ischaemic Heart Disease Risk Factor Study (Nutrition Component)Active, not recruitingNCT03221127
- Lipoprotein and Apolipoproteins With Metabolic Liver DiseasesStatus unknownNCT03220971
- Blood Ammonia as Predictor for Esophageal Varices and Risk of BleedingStatus unknownNCT03212872Not applicable
- Development and Clinical Application of Invalid Foods Using MealwormsStatus unknownNCT03201926Not applicable
- Assessing Kids for Liver Inflammation and Fibrosis Using Non-invasive MRICompletedNCT03198104
- Evaluation of 'Melody' Paracentesis Device for Ascites TherapyCompletedNCT03191851Not applicable
- Study Investigating the Pharmacokinetic Properties of the Drug Lu AF35700 in Subjects With Liver Impairment and in Healthy SubjectsCompletedNCT03189615Phase 1
- Effects of Dietary Intervention and Surgery on NAFLD (Non-Alcoholic Fatty Liver Disease)CompletedNCT03186859Not applicable
- Histological Improvement of NASH With PrebioticCompletedNCT03184376Not applicable
- Fatty Liver in Obesity: Long-lifestyle Follow-up (FLiO)Status unknownNCT03183193Not applicable
- Guangzhou Nutrition and Health Study (GNHS)Active, not recruitingNCT03179657
- Effect of Non-alcoholic Fatty Liver Disease on Kidney FunctionsStatus unknownNCT03172650
- Effect of Goal-directed Fluid Therapy on Postoperative ComplicationsCompletedNCT03169998
- Liver Fat and Iron Quantification MRICompletedNCT03162302
- Safety and Pharmacokinetics/Pharmacodynamics of SHR3824 in Patients With Hepatic ImpairmentStatus unknownNCT03160014Phase 1
- Global Osteopathic Treatment for Patients With NAFLDStatus unknownNCT03156881Not applicable
- Optimizing HBV Management During Anti-CD20 AntibodiesCompletedNCT03155984
- The Prevalence of Nonalcoholic Fatty Liver Disease (NAFLD) in AdultsTerminatedNCT03142867
- Mastiha Treatment for Obese With NAFLD DiagnosisCompletedNCT03135873Not applicable
- Inspiratory Muscle Training Post-Liver TransplantCompletedNCT03130608Not applicable
- Non-invasive Diagnosis of Non-alcoholic Steatohepatitis in Liver Transplant RecipientsStatus unknownNCT03128918
- The Effects of Melatonin on Elevated Liver Enzymes During Statins TreatmentCompletedNCT03121521Phase 4
- Single-Dose PK and Safety Study of GBT440 in Subjects With Hepatic ImpairmentCompletedNCT03114540Phase 1
- Autologous Endothelial Progenitor Cell Therapy for Reversal of Liver CirrhosisStatus unknownNCT03109236Phase 3
- Wet Heparin for Obtaining Liver Tissue for EUS Guided Liver BiopsyCompletedNCT03103997Not applicable
- Normothermic Liver Preservation TrialCompletedNCT03089840Phase 1/2
- Evaluation of HepQuant SHUNT to Assess Liver Disease; Substudy Within GS-US-416-2124WithdrawnNCT03087968Early Phase 1
- Postprandial Liver and Spleen Stiffness Measurements in the Noninvasive Diagnosis of CirrhosisCompletedNCT03087344Not applicable
- Vitamin D Replacement in Nonalcoholic Fatty Liver DiseaseCompletedNCT03084328
- An Open Label, Single-dose, Single Period ADME Study of A4250 in Healthy SubjectsCompletedNCT03082937Phase 1
- Impact of Text Messaging in the Management of Non-alcoholic Fatty Liver DiseaseCompletedNCT03082703Not applicable
- Application of 3D Visualization and 3D Printing in the Hepatobiliary and Pancreatic SurgeryStatus unknownNCT03074708Not applicable
- Omegaven for Compassionate Use in the Treatment of Parenteral Nutrition-Associated Liver DiseaseApproved for marketingNCT03072667
- A Reduced-carbohydrate Diet High in Monounsaturated Fats in Type 2 DiabetesCompletedNCT03068078Not applicable
- Antidiabetic Effects on Intrahepatic FatCompletedNCT03068065Phase 4
- Effects of Fructose Restriction on Liver SteatosisCompletedNCT03067428Not applicable
- Randomised Controlled Study of Popofol Versus Midazolam as Sedation in Endoscopy With Advanced Liver Disease.Status unknownNCT03063866Phase 4
- Screening Diabetes Patients for NAFLD With Controlled Attenuation Parameter and Liver Stiffness MeasurementsCompletedNCT03060694
- A Multiple Ascending Dose Study to Evaluate Safety and Tolerability of BFKB8488A in Participants With Type 2 Diabetes Mellitus and Participants With Non-Alcoholic Fatty Liver DiseaseCompletedNCT03060538Phase 1
- Pharmacokinetics of Fevipiprant (QAW039) in Patients With Hepatic Impairment Compared to Matched Healthy SubjectsCompletedNCT03048448Phase 1
- Hypothermic Oxygenated Perfusion Versus Static Cold Storage for Marginal GraftCompletedNCT03031067Not applicable
- Longitudinal Assessment of Transient Elastography in Cystic FibrosisCompletedNCT03001388
- Longitudinal Outcomes in Hepatic ResectionWithdrawnNCT02997098
- Weight Loss Effect on Circulating Liver EnzymesCompletedNCT02992639Not applicable
- The Effects of Dexamethasone Administration on Jaundice Following Liver ResectionCompletedNCT02991339Phase 2/3
- A Study to Evaluate the Pharmacokinetics of BMS-986141 in Participants With Hepatic Impairment Compared to Healthy ParticipantsWithdrawnNCT02985632Phase 1
- The Effects of Zataria Multiflora Boiss (Shirazi's Thyme) on Nonalcoholic Fatty Liver DiseaseCompletedNCT02983669Not applicable
- MRI to Characterize and Predict CF Liver Disease in PUSH CohortCompletedNCT02979340
- Single Dose of PF-06835919 Escalation Study in Healthy Adult SubjectsCompletedNCT02974374Phase 1
- Silymarin in NAFLDWithdrawnNCT02973295Phase 4
- Evaluation of the Effects of a L.Reuteri Strain on Markers of Inflammation, Cardiovascular Risk and Fatty Liver DiseaseCompletedNCT02972567Not applicable
- Exploring Biomarkers Predicting the Outcome of Acute-on-chronic Liver FailureCompletedNCT02965560
- Study on Mechanisms of Changes in Liver Disease and Sex Steroid Metabolism During Weight LossCompletedNCT02964780
- A Safety and Pharmakokinetic Study of A4250 Alone or in Combination With A3384CompletedNCT02963077Phase 1
- Metabolic Flexibility, Gut Microbiota, Healthy Diet and Exercise in NAFLD on Genetics BaseCompletedNCT02951546Not applicable
- Breath Analysis Using an Electronic Nose in Non Alcoholic Fatty Liver DiseaseCompletedNCT02950610
- Evidence-based Laboratory Test Order Sets in Primary CareCompletedNCT02950142Not applicable
- Impact of Exercise Therapy on Functional Capacity in Patients Listed for Liver TransplantationCompletedNCT02949505Not applicable
- Low-dose IL-2 for Treg Expansion and Tolerance (LITE)TerminatedNCT02949492Phase 4
- Trial to Examine the Effect of Two Doses of GRI-0621 in Patients With Chronic Liver DiseaseTerminatedNCT02949375Phase 2
- Half-life of Plasma Phytosterols in Very Low Birth Weight Preterm Infants With Parenteral Nutrition-associated CholestasisCompletedNCT02947594
- Genetical Background of Non-alcoholic Fatty Liver Disease (NAFLD) in Diabetes Mellitus and in Chronic Kidney DiseaseStatus unknownNCT02947568
- Autologous Bone Marrow Stem Cells Infusion for the Treatment of Liver Diseases.Status unknownNCT02943707Phase 2
- Effect of Synbiotic on Postoperative Complications After Liver TransplantationStatus unknownNCT02938871Not applicable
- Runihol in Nonalcoholic Fatty Liver Disease and Metabolic SyndromeTerminatedNCT02930161Phase 2
- Liver Disease in Patients With alpha1-antitrypsin DeficiencyStatus unknownNCT02929940
- A Study of the Efficacy and Safety of CF102 in the Treatment of Non-Alcoholic Fatty Liver DiseaseCompletedNCT02927314Phase 2
- Safety and Tolerability of VK2809 in Patients With Primary Hypercholesterolemia and Non-Alcoholic Fatty Liver DiseaseCompletedNCT02927184Phase 2
- Expanded Access Use of Omegaven® in the Treatment of Parenteral Nutrition Induced Liver Injury in ChildrenNo longer availableNCT02925520
- FibroScan™ in Pediatric Cholestatic Liver Disease (FORCE)CompletedNCT02922751
- Retrospective Study About Primary Biliary Cholangitis During January 2001 to July 2016 at West China HospitalCompletedNCT02917408
- Evolution and Clinical Outcomes in Patients Undergoing Liver TransplantationStatus unknownNCT02917382
- Extracellular RNA Markers of Liver Disease and CancerTerminatedNCT02908048
- Effects of Whey Protein Consumption by Patients Waiting for Liver TransplantationStatus unknownNCT02901119Not applicable
- FDGal PET/CT to Detect Hepatocellular CarcinomaWithdrawnNCT02899325
- The Role and Dynamics of Liver Dysfunction in Patients Undergoing Cardiac SurgeryStatus unknownNCT02893657
- French HIV-HBV CohortStatus unknownNCT02889094
- Rifaximin Modify the Pathogenesis of Non-Alcoholic Fatty Liver Disease (NAFLD)CompletedNCT02884037
- Influence of CYP3A5 Polymorphism on Liver Function Abnormality and the Trough Level Change After ConversionStatus unknownNCT02882113Phase 4
- Patient Understanding of LiverMultiScanCompletedNCT02877602
- Biomarkers for the Detection of Heavy Alcohol Use in Patients With and Without Liver DiseaseActive, not recruitingNCT02873663Not applicable
- Pharmacokinetics of Dabrafenib in Subjects With Hepatic ImpairmentTerminatedNCT02873650Phase 1
- Diaphragmatic Breathing Exercise Improves Non-alcoholic Fatty Liver DiseaseWithdrawnNCT02863393Not applicable
- Using Infrared Spectroscopy for Diagnosis Severity of Nonalcoholic Fatty Liver DiseaseCompletedNCT02860884
- Comparison of Response and Recurrence Rates Following Percutaneous Microwave Coagulation Therapy Versus Percutaneous Radiofrequency AblationCompletedNCT02859753Not applicable
- A Trial to Evaluate the Pharmacokinetics of ABL001 in Healthy and Hepatic Impaired SubjectsCompletedNCT02857868Phase 1
- Branched-chain Amino Acid (BCAA) on Progression of Advanced Liver DiseaseStatus unknownNCT02837302Phase 4
- The Impact of Bariatric Surgery on Non-alcoholic Fatty Liver DiseaseCompletedNCT02828579
- AZD4076 in Type 2 Diabetic Subjects With Non-Alcoholic Fatty Liver Disease.CompletedNCT02826525Phase 1